共 53 条
- [2] Risk of stroke/systemic embolism, major bleeding and associated costs in non-valvular atrial fibrillation patients who initiated apixaban, dabigatran or rivaroxaban compared with warfarin in the United States Medicare population [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2017, 33 (09) : 1595 - 1604
- [3] Risks and benefits of direct oral anticoagulants versus warfarin in a real world setting: cohort study in primary care (vol 362, k2505, 2018) [J]. BMJ-BRITISH MEDICAL JOURNAL, 2018, 363
- [4] ( AWMSG) AWMSG, 2020, ALL WAL ADV OR ANT N
- [7] Bayer, XAR SMPC 2022
- [10] Board. NIHaSC, 2022, NO IR FORM 2 8 2 1 A